RECURRENT ADULT GRADE III LYMPHOMATOID GRANULOMATOSIS
Clinical trials for RECURRENT ADULT GRADE III LYMPHOMATOID GRANULOMATOSIS explained in plain language.
Never miss a new study
Get alerted when new RECURRENT ADULT GRADE III LYMPHOMATOID GRANULOMATOSIS trials appear
Sign up with your email to follow new studies for RECURRENT ADULT GRADE III LYMPHOMATOID GRANULOMATOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Engineered T-Cells show promise in lymphoma fight
Disease control OngoingThis early-phase study tests a new immune therapy for people with high-risk or returning non-Hodgkin lymphoma. After a stem cell transplant, patients receive specially modified T-cells designed to find and attack cancer cells. The main goal is to check safety and find the best do…
Matched conditions: RECURRENT ADULT GRADE III LYMPHOMATOID GRANULOMATOSIS
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated May 14, 2026 12:03 UTC
-
New CMV strategy aims to protect stem cell transplant patients from dangerous infection
Disease control OngoingThis study looks at a modified approach to prevent and treat cytomegalovirus (CMV) infection in people who have had a donor stem cell transplant for blood cancers or disorders. About 153 participants are involved, and the goal is to see if changing when and how anti-CMV drugs are…
Matched conditions: RECURRENT ADULT GRADE III LYMPHOMATOID GRANULOMATOSIS
Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated May 13, 2026 16:02 UTC